e p i l e p s y u p d a t e
TRANSCRIPT
![Page 1: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/1.jpg)
Epilepsy & Anti-epileptic Drugs
Dr. B. K. Iyer
![Page 2: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/2.jpg)
Epilepsy
The background
![Page 3: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/3.jpg)
Epilepsy• Seizures
– Incidence: approximately 80/100,000 per year– Lifetime prevalence: 9%
(1/3 benign febrile convulsions)
• Epilepsy – Incidence: approximately 45/100,000 per year– 45-100 million people worldwide.
• There are 2.5 million Americans with epilepsy in the US alone.
• Therapy is symptomatic in that the majority of drugs prevent seizures, but neither effective prophylaxis nor cure is available.
![Page 4: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/4.jpg)
Epilepsy
• Epileptogenesis: sequence of events that converts a normal neuronal network into a hyperexcitable network
• A group of chronic CNS disorders characterized by a tendency toward recurrent seizures unprovoked by any systemic or acute neurologic insults.
![Page 5: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/5.jpg)
Seizures• Seizures are sudden, transitory, and uncontrolled episodes
of brain dysfunction resulting from abnormal discharge of neuronal cells with associated motor, sensory or behavioral changes.
• The causes for seizures can be multiple, from infection, to neoplasms, to head injury. In a few subgroups it is an inherited disorder.
• Febrile seizures or seizures caused by meningitis are treated by antiepileptic drugs, although they are not considered epilepsy (unless they develop into chronic seizures).
• Seizures may also be caused by acute underlying toxic or metabolic disorders, in which case the therapy should be directed towards the specific abnormality.
![Page 6: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/6.jpg)
Causes for Acute Seizures• Trauma• Encephalitis• Drugs• Birth trauma• Withdrawal from
depressants• Tumor
• High fever• Hypoglycemia• Extreme acidosis• Extreme alkalosis• Hyponatremia• Hypocalcemia• Idiopathic
![Page 7: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/7.jpg)
Neuronal Substrates of Epilepsy
The Brain
The Synapse
The Ion Channels/Receptors
ions
![Page 8: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/8.jpg)
Cellular and Synaptic Mechanisms of Epileptic Seizures
(From Brody et al., 1997)
![Page 9: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/9.jpg)
Cellular mechanisms of seizure generation
• Excitation (too much) – Ionic—inward Na+, Ca++ currents– Neurotransmitter—glutamate, aspartate
• Inhibition (too little)– Ionic—inward CI-, outward K+ currents– Neurotransmitter—GABA
![Page 10: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/10.jpg)
Neuronal (Intrinsic) factors modifying neuronal excitability
• Ion channel type, number, and distribution
• Biochemical modification of receptors
• Activation of second-messenger systems
• Modulation of gene expression (e.g., for receptor proteins)
![Page 11: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/11.jpg)
Extra-Neuronal (Extrinsic) factors modifying neuronal excitability
• Changes in extracellular ion concentration
• Remodeling of synapse location or configuration by afferent input
• Modulation of transmitter metabolism or uptake by glial cells
![Page 12: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/12.jpg)
Mechanisms of generating hyperexcitable networks
• Excitatory axonal “sprouting”
• Loss of inhibitory neurons
• Loss of excitatory neurons “driving” inhibitory neurons
![Page 13: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/13.jpg)
Hippocampal Circuitry and Seizures
![Page 14: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/14.jpg)
Basic mechanisms underlying seizures & epilepsy
Feedback and feed-forward inhibition, illustrated via cartoon and schematic of simplified hippocampal circuit
Babb TL, Brown WJ. Pathological Findings in Epilepsy. In: Engel J. Jr. Ed. Surgical Treatment of the Epilepsies. New York: Raven Press 1987: 511-540.
![Page 15: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/15.jpg)
Epilepsy types
The background
![Page 16: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/16.jpg)
Classification of Epileptic Seizures1. Partial (focal) Seizures
a) Simple Partial Seizuresb) Complex Partial Seizures
2. Generalized Seizuresa) Generalized Tonic-Clonic Seizuresb) Absence Seizuresc) Tonic Seizuresd) Atonic Seizurese) Clonic Seizuresf) Myoclonic Seizuresg) Infantile Spasms
![Page 17: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/17.jpg)
Adult Seizure Types
• Complex partial seizures - 40%
• Simple partial seizures - 20%
• Primary generalized tonic-clonic seizures - 20%
• Absence seizures - 10%
• Other seizure types - 10%
• In a pediatric population, absence seizures occupy a greater proportion
![Page 18: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/18.jpg)
Insights into epilepsy
![Page 19: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/19.jpg)
I. Partial (Focal) Seizures
• Simple Partial Seizures
• Complex Partial Seizures.
![Page 20: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/20.jpg)
Scheme of Seizure Spread
Simple (Focal) Partial Seizures
Contralateral spread
![Page 21: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/21.jpg)
I. Partial (Focal) SeizuresA. Simple Partial Seizures (Jacksonian)
– Involves one side of the brain at onset.– Focal w/motor, sensory or speech disturbances.– Confined to a single limb or muscle group.– Seizure-symptoms don’t change during seizure.– No alteration of consciousness.
• EEG: Excessive synchronized discharge by a small group of neurons. Contralateral discharge.
![Page 22: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/22.jpg)
Scheme of Seizure Spread
Complex Partial Seizures
Complex Secondarily Generalized Partial Seizures
![Page 23: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/23.jpg)
I. Partial (focal) SeizuresB. Complex Partial Seizures (Temporal Lobe
epilepsy or Psychomotor Seizures)– Produces confusion and inappropriate or dazed
behavior.– Motor activity appears as non-reflex actions.
Automatisms (repetitive coordinated movements).– Wide variety of clinical manifestations.– Consciousness is impaired or lost.
• EEG: Bizarre generalized EEG activity with evidence of anterior temporal lobe focal abnormalities. Bilateral.
![Page 24: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/24.jpg)
II. Generalized Seizures
A. Generalized Tonic-Clonic Seizures
B. Absence Seizures
C. Tonic Seizures
D. Atonic Seizures
E. Clonic Seizures
F. Myoclonic Seizures.
G. Infantile Spasms
![Page 25: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/25.jpg)
II. Generalized Seizures• In Generalized seizures,
both hemispheres are widely involved from the outset.
• Manifestations of the seizure are determined by the cortical site at which the seizure arises.
• Present in 40% of all epileptic Syndromes.
![Page 26: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/26.jpg)
II. Generalized SeizuresA. Generalized Tonic-Clonic Seizures
Recruitment of neurons throughout the cerebrum
Major convulsions, usually with 2 phases:1) Tonic phase2) Clonic phase
Convulsions: – motor manifestations– may or may not be present during seizures– excessive neuronal discharge
Convulsions appear in Simple Partial and Complex Partial Seizures if the focal neuronal discharge includes motor centers; they occur in all Generalized Tonic-Clonic Seizures regardless of the site of origin.
Atonic, Akinetic, and Absence Seizures are non-convulsive
![Page 27: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/27.jpg)
II. Generalized Seizures
• Neuronal Correlates of Paroxysmal Discharges
![Page 28: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/28.jpg)
II. Generalized Seizures
A. Generalized Tonic-Clonic Seizures
• Tonic phase:– Sustained powerful muscle contraction (involving all
body musculature) which arrests ventilation.
• EEG: Rythmic high frequency, high voltage discharges with cortical neurons undergoing sustained depolarization, with protracted trains of action potentials.
![Page 29: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/29.jpg)
II. Generalized Seizures
A. Generalized Tonic-Clonic Seizures
• Clonic phase:– Alternating contraction and relaxation, causing a
reciprocating movement which could be bilaterally symmetrical or “running” movements.
• EEG: Characterized by groups of spikes on the EEG and periodic neuronal depolarizations with clusters of action potentials.
![Page 30: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/30.jpg)
Scheme of Seizure Spread
Both hemispheres areinvolved from outset
Generalized Tonic-Clonic Seizures
![Page 31: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/31.jpg)
Neuronal Correlates of Paroxysmal Discharges
![Page 32: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/32.jpg)
II. Generalized Seizures
B. Absence Seizures (Petite Mal)– Brief and abrupt loss of consciousness, vacant stare.– Sometimes with no motor manifestations.– Minor muscular twitching restricted to eyelids (eyelid
flutter) and face. – Typical 2.5 – 3.5 Hz spike-and-wave discharge.– Usually of short duration (5-10 sec), but may occur
dozens of times a day.– No loss of postural control.
![Page 33: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/33.jpg)
II. Generalized Seizures
• Neuronal Correlates of Paroxysmal Discharges
Generalized Absence Seizures
![Page 34: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/34.jpg)
II. Generalized SeizuresB. Absence Seizures
• Often begin during childhood (daydreaming attitude, no participation, lack of concentration).
• A low threshold Ca2+ current has been found to govern oscillatory responses in thalamic neurons (pacemaker) and it is probably involve in the generation of these types of seizures.
EEG: Bilaterally synchronous, high voltage 3-per-second spike-and-wave discharge pattern.
Spike-wave phase: Neurons generate short duration depolarization and a burst of action potentials, but there is no sustained depolarization or repetitive firing of action potentials.
![Page 35: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/35.jpg)
Thalamocortial relays are believed
to act on a hyperexcitable
cortex
Scheme of Seizure Spread
Primary GeneralizedAbsence Seizures
![Page 36: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/36.jpg)
Scheme of Seizure Spread
![Page 37: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/37.jpg)
II. Generalized Seizure
C. Tonic Seizures– Opisthotonus, loss of consciousness.– Marked autonomic manifestations
![Page 38: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/38.jpg)
II. Generalized Seizure
C. Tonic Seizures– Opisthotonus, loss of consciousness.– Marked autonomic manifestations
D. Atonic Seizures (atypical)– Loss of postural tone, with sagging of the head or
falling.– May loose consciousness.
![Page 39: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/39.jpg)
II. Generalized Seizure
E. Clonic Seizures– Clonic Seizures: Rhythmic clonic contractions of all
muscles, loss of consciousness, and marked autonomic manifestations.
F. Myoclonic Seizures– Myoclonic Seizures: Isolated clonic jerks associated
with brief bursts of multiple spikes in the EEG.
![Page 40: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/40.jpg)
II. Generalized Seizures
F. Infantile Spasms– An epileptic syndrome.– Attacks, although fragmentary, are often bilateral.– Characterized by brief recurrent myoclonic jerks of the
body with sudden flexion or extension of the body and limbs.
![Page 41: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/41.jpg)
Treatment of Seizures• Goals:
– Block repetitive neuronal firing.– Block synchronization of neuronal discharges.– Block propagation of seizure.
• Minimize side effects with the simplest drug regimen.
• MONOTHERAPY IS RECOMMENDED IN MOST CASES
![Page 42: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/42.jpg)
Treatment of Seizures
• Strategies:1. Modification of ion conductances.
2. Increase inhibitory (GABAergic) transmission.
3. Decrease excitatory (glutamatergic) activity.
![Page 43: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/43.jpg)
Treatment of Seizures
A. Hydantoins: phenytoin
B. Barbiturates: phenobarbital
C. Oxazolidinediones: trimethadione
D. Succinimides: ethosuximide
E. Acetylureas: phenacemide
F. Other: carbamazepine, lamotrigine, vigabatrin, etc.
G. Diet
H. Surgery, Vagus Nerve Stimulation (VNS).
![Page 44: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/44.jpg)
Antiepileptic Drug
• A drug which decreases the frequency and/or severity of seizures in people with epilepsy
• Treats the symptom of seizures, not the underlying epileptic condition
• Goal—maximize quality of life by minimizing seizures and adverse drug effects
• Currently no “anti-epileptogenic” drugs available
![Page 45: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/45.jpg)
Current Pharmacotherapy
• Just under 60% of all people with epilepsy can become seizure free with drug therapy
• In another 20%, the seizures can be drastically reduced
• ~ 20% epileptic patients, seizures are refractory to currently available AEDs
![Page 46: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/46.jpg)
Epilepsy therapy
The background
![Page 47: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/47.jpg)
Targets for AEDs
1. Increase inhibitory neurotransmitter system—GABA
2. Decrease excitatory neurotransmitter system—glutamate
3. Block voltage-gated inward positive currents—Na+ or Ca++
4. Increase outward positive current—K+
5. Many AEDs pleiotropic—act via multiple mechanisms
![Page 48: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/48.jpg)
History of Antiepileptic Drug Therapy• 1857 - Bromides• 1912 - Phenobarbital• 1937 - Phenytoin• 1954 - Primidone• 1960 – Ethosuximide• 1974 - Carbamazepine• 1975 – Clonazepam (benzodiazapine)• 1978 - Valproate• 1993 - Felbamate, Gabapentin• 1995 - Lamotrigine• 1997 - Topiramate, Tiagabine• 1999 - Levetiracetam• 2000 - Oxcarbazepine, Zonisamide• Vigabatrin—not approved in US
![Page 49: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/49.jpg)
Anti-epileptics
![Page 50: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/50.jpg)
Anti-epileptics
![Page 51: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/51.jpg)
Actions of Phenytoin on Na+ Channels• Resting State
Sustain
channel in
this
conformation
• Arrival of Action Potential causes depolarization and channel opens allowing sodium to flow in.
• Refractory State, Inactivation
![Page 52: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/52.jpg)
Ca2+ Channels• Ion Channels
– Voltage-gated
– Multiple Ca2+ mediated events
– Missense mutations of the T-type Ca-channel 1H subunit is associated with Childhood Absence Epilepsy in Northern China
• Drugs Used:– Calcium Channel Blockers
B
![Page 53: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/53.jpg)
GABAergic SYNAPSE• Drugs that Act at the
GABAergic Synapse– GABA agonists
– GABA antagonists
– Barbiturates
– Benzodiazepines
– GABA uptake inhibitors
• Goal : GABA Activity
![Page 54: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/54.jpg)
GLUTAMATERGIC SYNAPSE• Excitatory Synapse.
– Permeable to Na+, Ca2+ and K+.
– Magnesium ions block channel in resting state.
– Glycine (GLY) binding enhances the ability of GLU or NMDA to open the channel.
– Agonists: NMDA, AMPA, Kianate.
• Goal: GLU Activity
![Page 55: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/55.jpg)
GLUTAMATERGIC SYNAPSE
![Page 56: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/56.jpg)
Antiepileptics
The background
![Page 57: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/57.jpg)
Choosing Antiepileptic Drugs Seizure type Epilepsy syndrome Pharmacokinetic profile Interactions/other medical conditions Efficacy Expected adverse effects Cost
![Page 58: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/58.jpg)
General facts about AEDs
• Good oral absorption and bioavailability
• Most metabolized in liver but some excreted unchanged in kidneys
• Classic AEDs generally have more severe CNS sedation than newer drugs (except ethosuximide)
• Because of overlapping mechanisms of action, best drug can be chosen based on minimizing side effects in addition to efficacy
• Add-on therapy is used when a single drug does not completely control seizures
![Page 59: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/59.jpg)
Chemical Structure of Classical Antiseizure Agents
X may vary as follows:
Barbiturates - C – N -
Hydantoins - N –
Oxazolidinediones – O –
Succinimides – C –
Acetylureas - NH2 –*
*(N connected to C2)
Small changes can alter clinical activity and site of action.e.g. At R1, a phenyl group (phenytoin) confers activity against partial seizures, but an alkyl group (ethosuximide) confers activity against generalized absence seizures.
![Page 60: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/60.jpg)
Treatment of Seizures• Structurally dissimilar drugs:
– Carbamazepine– Valproic acid– BDZs.
• New compounds:– Felbamate (Japan)– Gabapentin– Lamotrigine– Tiagabine– Topiramate– Vigabatrin
![Page 61: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/61.jpg)
Pharmacokinetic Parameters
![Page 62: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/62.jpg)
Effects of 3 antiepileptic drugs on high frequency discharge of cultured neurons
.
(From Katzung B.G., 2001)
Block of sustained high frequency repetitive firing of action potentials.
![Page 63: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/63.jpg)
PHENYTOIN (Dilantin)• Oldest nonsedative antiepileptic
drug.• Fosphenytoin, a more soluble
prodrug is used for parenteral use.
• “Fetal hydantoin syndrome”• It alters Na+, Ca2+ and K+
conductances.• Inhibits high frequency
repetitive firing.• Alters membrane potentials.• Alters a.a. concentration.• Alters NTs (NE, ACh, GABA)
Toxicity:•Ataxia and nystagmus.•Cognitive impairment.•Hirsutism•Gingival hyperplasia.•Coarsening of facial features.•Dose-dependent zero order kinetics.•Exacerbates absence seizures.
![Page 64: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/64.jpg)
Fetal Hydantoin Syndrome• Pre- and postnatal growth deficiency with
psychomotor retardation, microcephaly with a ridged metopic suture, hypoplasia of the nails and finger-like thumb and hypoplasia of the distal phalanges.
• Radiological skeletal abnormalities reflect the hypoplasia and fused metopic suture.
• Cardiac defects and abnormal genitalia.
Teratogenicity of several anticonvulsant medications is associated with an elevated level of oxidative metabolites that are normally eliminated by the enzyme epoxide hydrolase.
![Page 65: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/65.jpg)
CARBAMAZEPINE (Tegretol)• Tricyclic, antidepressant (bipolar)• 3-D conformation similar to
phenytoin.• Mechanism of action, similar to
phenytoin. Inhibits high frequency repetitive firing.
• Decreases synaptic activity presynaptically.
• Binds to adenosine receptors (?).• Inh. uptake and release of NE, but
not GABA.• Potentiates postsynaptic effects of
GABA.• Metabolite is active.
Toxicity:•Autoinduction of metabolism.•Nausea and visual disturbances.•Granulocyte supression.•Aplastic anemia.•Exacerbates absence seizures.
![Page 66: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/66.jpg)
OXCARBAZEPINE (Trileptal)
• Closely related to carbamazepine.
• With improved toxicity profile.• Less potent than
carbamazepine.• Active metabolite.• Mechanism of action, similar
to carbamazepine It alters Na+
conductance and inhibits high frequency repetitive firing.
Toxicity:•Hyponatremia•Less hypersensitivityand induction of hepaticenzymes than with carb.
![Page 67: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/67.jpg)
PRIMIDONE (Mysolin)• Metabolized to phenobarbital and
phenylethylmalonamide (PEMA), both active metabolites.
• Effective against partial and generalized tonic-clonic seizures.
• Absorbed completely, low binding to plasma proteins.
• Should be started slowly to avoid sedation and GI problems.
• Its mechanism of action may be closer to phenytoin than the barbiturates.
Toxicity:•Same as phenobarbital•Sedation occurs early.•Gastrointestinal complaints.
![Page 68: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/68.jpg)
VALPROATE• Fully ionized at body pH, thus
active form is valproate ion.• One of a series of carboxylic acids
with antiepileptic activity. Its amides and esters are also active.
• Mechanism of action, similar to phenytoin.
levels of GABA in brain.• May facilitate Glutamic acid
decarboxylase (GAD).
• Inhibits GAT-1. [aspartate]Brain?
• May increase membrane potassium conductance.
Toxicity:•Elevated liver enzymes including own.•Nausea and vomiting.•Abdominal pain and heartburn.•Tremor, hair loss, •Weight gain.•Idiosyncratic hepatotoxicity.•Negative interactions with other antiepileptics.•Teratogen: spina bifida
![Page 69: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/69.jpg)
ETHOSUXIMIDE• Drug of choice for absence seizures.• High efficacy and safety.• VD = TBW.• Not plasma protein or fat binding• Mechanism of action involves
reducing low-threshold Ca2+ channel current (T-type channel) in thalamus.
At high concentrations:• Inhibits Na+/K+ ATPase.• Depresses cerebral metabolic rate.• Inhibits GABA aminotransferase.
• Phensuximide = less effective• Methsuximide = more toxic
Toxicity:•Gastric distress, including, pain, nausea and vomiting•Lethargy and fatigue•Headache•Hiccups•Euphoria•Skin rashes•Lupus erythematosus (?)
![Page 70: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/70.jpg)
CLONAZEPAM• A benzodiazepine.• Long acting drug with efficacy
for absence seizures.• One of the most potent
antiepileptic agents known.• Also effective in some cases of
myoclonic seizures.• Has been tried in infantile
spasms.• Doses should start small. • Increases the frequency of Cl-
channel opening.
Toxicity:• Sedation is prominent. • Ataxia.• Behavior disorders.
![Page 71: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/71.jpg)
VIGABATRIN (-vinyl-GABA)
• Absorption is rapid, bioavailability is ~ 60%, T 1/2 6-8 hrs, eliminated by the kidneys.
• Use for partial seizures and West’s syndrome.
• Contraindicated if preexisting mental illness is present.
• Irreversible inhibitor of GABA-aminotransferase (enzyme responsible for metabolism of GABA) => Increases inhibitory effects of GABA.
• S(+) enantiomer is active.
Toxicity:•Drowsiness•Dizziness•Weight gain
•Agitation•Confusion•Psychosis
![Page 72: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/72.jpg)
LAMOTRIGINE (Lamictal)
• Presently use as add-on therapy with valproic acid (v.a. conc. are be reduced).
• Almost completely absorbed• T1/2 = 24 hrs• Low plasma protein binding • Also effective in myoclonic and
generalized seizures in childhood and absence attacks.
• Suppresses sustained rapid firing of neurons and produces a voltage and use-dependent inactivation of sodium channels, thus its efficacy in partial seizures.
Toxicity:•Dizziness•Headache•Diplopia•Nausea•Somnolence•Rash
![Page 73: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/73.jpg)
FELBAMATE
• Effective against partial seizures but has severe side effects.
• Because of its severe side effects, it has been relegated to a third-line drug used only for refractory cases.
Toxicity:•Aplastic anemia•Severe hepatitis
![Page 74: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/74.jpg)
TOPIRAMATE• Rapidly absorbed, bioav. is >
80%, has no active metabolites, excreted in urine.T1/2 = 20-30 hrs
• Blocks repetitive firing of cultured neurons, thus its mechanism may involve blocking of voltage-dependent sodium channels
• Potentiates inhibitory effects of GABA (acting at a site different from BDZs and BARBs).
• Depresses excitatory action of kainate on AMPA receptors.
• Teratogenic in animal models.
Toxicity:• Somnolence• Fatigue• Dizziness• Cognitive slowing• Paresthesias• Nervousness• Confusion• Urolithiasis
![Page 75: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/75.jpg)
ZONISAMIDE
• Sulfonamide derivative.• Marketed in Japan.• Good bioavailability, low pb.• T1/2 = 1 - 3 days• Effective against partial and
generalized tonic-clonic seizures.
• Mechanism of action involves voltage and use-dependent inactivation of sodium channels (?).
• May also involve Ca2+ channels.
Toxicity:•Drowsiness•Cognitive impairment•High incidence of renal stones (?).
![Page 76: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/76.jpg)
GABAPENTIN• Used as an adjunct in partial and
generalized tonic-clonic seizures.• Does not induce liver enzymes.• not bound to plasma proteins.• drug-drug interactions are
negligible.• Low potency.• An a.a.. Analog of GABA that
does not act on GABA receptors, it may however alter its metabolism, non-synaptic release and transport.
Toxicity:•Somnolence.•Dizziness.•Ataxia.•Headache.•Tremor.
![Page 77: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/77.jpg)
Status Epilepticus
• Status epilepticus exists when seizures recur within a short period of time , such that baseline consciousness is not regained between the seizures.
• They last for at least 30 minutes.
• Can lead to systemic hypoxia, acidemia, hyperpyrexia, cardiovascular collapse, and renal shutdown.
The most common, generalized tonic-clonic status epilepticus is life-threatening and must be treated immediately with concomitant cardiovascular, respiratory and metabolic
management.
![Page 78: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/78.jpg)
DIAZEPAM & LORAZEPAM
• Benzodiazepines.• Will also be discussed with
Sedative hypnotics.• Given I.V.• Lorazepam may be longer acting.• 1° for treating status epilepticus• Have muscle relaxant activity.• Allosteric modulators of GABA
receptors.• Potentiates GABA function, by
increasing the frequency of channel opening.
Toxicity•Sedation•Children may manifest a paradoxical hyperactivity.•Tolerance
![Page 79: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/79.jpg)
Treatment of Status Epilepticus in Adults
• Initial– Diazepam, i.v. 5-10 mg (1-2 mg/min)
• repeat dose (5-10 mg) every 20-30 min.
– Lorazepam, i.v. 2-6 mg (1 mg/min) • repeat dose (2-6 mg) every 20-30 min.
• Follow-up– Phenytoin, i.v. 15-20 mg/Kg (30-50 mg/min).
• repeat dose (100-150 mg) every 30 min.
– Phenobarbital, i.v. 10-20 mg/Kg (25-30mg/min).• repeat dose (120-240 mg) every 20 min.
![Page 80: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/80.jpg)
Treatment of Seizures• PARTIAL SEIZURES ( Simple and Complex,
including secondarily generalized)• Drugs of choice:
– Carbamazepine – Phenytoin– Valproate
• Alternatives:– Lamotrigine, phenobarbital, primidone,
oxcarbamazepine.
• Add-on therapy: – Gabapentin, topiramate, tiagabine, levetiracetam,
zonisamide.
![Page 81: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/81.jpg)
Treatment of Seizures
• PRIMARY GENERALIZED TONIC-CLONIC SEIZURES (Grand Mal)
• Drugs of choice: – Carbamazepine – Phenytoin– Valproate*
• Alternatives:– Lamotrigine, phenobarbital, topiramate, oxcartbazepine,
primidone, levetiracetam, phenobarbital.• *Not approved except if absence seizure is involved
![Page 82: E P I L E P S Y U P D A T E](https://reader035.vdocuments.site/reader035/viewer/2022081514/554b1d8ab4c9056f098b51e4/html5/thumbnails/82.jpg)
Infantile Spasms• This is an epileptic syndrome and not a seizure type.• The attacks although sometimes fragmentary are most often
bilateral and are included, for pragmatic purposes, with the generalized seizures.
• Characterized by recurrent myoclonic jerks with sudden flexion or extension of the body and limbs; the form of infantile spasms are, however, quite heterogeneous.
• 90% have their first attack before the age of 1 year.• Most patients are mentally retarded, presumably from the
same cause of the spasms.• The cause is unknown. Infections, kernicterus, tuberous
sclerosis and hypoglycemia have all been implicated.